| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.857 | 0.003 | 0.941 | Platelet activating factor beta antagonist | 0.941 0.002 CID_18445712 0.288 0.012 CID_18445703 | CID_18445712 | |
| 0.754 | 0.004 | 0.929 | Platelet aggregation inhibitor | 0.929 0.003 CID_18445712 0.422 0.016 CID_18445703 | CID_18445712 | |
| 0.725 | 0.004 | 0.885 | Platelet activating factor antagonist | 0.885 0.003 CID_18445712 0.161 0.039 CID_18445703 | CID_18445712 | |
| 0.718 | 0.008 | 0.718 | Angiogenesis inhibitor | 0.418 0.048 CID_18445712 0.204 0.165 CID_18445703 | ||
| 0.628 | 0.005 | 0.628 | Vascular endothelial growth factor antagonist | |||
| 0.619 | 0.004 | 0.619 | Vascular endothelial growth factor 1 antagonist | |||
| 0.59 | 0.005 | 0.59 | Vascular endothelial growth factor 2 antagonist | |||
| 0.572 | 0.008 | 0.572 | Antimitotic | 0.221 0.073 CID_18445712 0.239 0.064 CID_18445703 | ||
| 0.533 | 0.005 | 0.533 | Aurora-A kinase inhibitor | |||
| 0.524 | 0.005 | 0.524 | Vascular endothelial growth factor 3 antagonist | |||
| 0.495 | 0.012 | 0.495 | Growth factor antagonist | |||
| 0.504 | 0.052 | 0.504 | MAP kinase 1 inhibitor | |||
| 0.43 | 0.005 | 0.43 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.43 | 0.005 | 0.43 | Abl kinase inhibitor | |||
| 0.433 | 0.013 | 0.433 | Death-associated protein kinase 3 inhibitor | |||
| 0.428 | 0.009 | 0.428 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.441 | 0.023 | 0.441 | Tyrosine kinase inhibitor | |||
| 0.443 | 0.037 | 0.443 | MAP kinase kinase 6 inhibitor | 0.256 0.182 CID_18445712 | ||
| 0.408 | 0.007 | 0.408 | Aurora-B kinase inhibitor | |||
| 0.405 | 0.006 | 0.405 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.404 | 0.017 | 0.404 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.378 | 0.01 | 0.378 | Glycogen synthase kinase-3 inhibitor | |||
| 0.38 | 0.012 | 0.38 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.351 | 0.01 | 0.351 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.351 | 0.013 | 0.351 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.359 | 0.021 | 0.359 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.349 | 0.025 | 0.349 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.338 | 0.016 | 0.338 | RET inhibitor | |||
| 0.335 | 0.018 | 0.335 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.322 | 0.014 | 0.322 | Protein kinase (CK1) gamma inhibitor | |||
| 0.311 | 0.007 | 0.311 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.317 | 0.016 | 0.317 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.317 | 0.021 | 0.317 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.311 | 0.022 | 0.311 | Protein kinase C nu inhibitor | |||
| 0.294 | 0.012 | 0.294 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.31 | 0.03 | 0.31 | ErbB-1 antagonist | |||
| 0.302 | 0.026 | 0.302 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.16 0.11 CID_18445703 | ||
| 0.272 | 0.005 | 0.272 | Check point kinase 1 inhibitor | |||
| 0.286 | 0.021 | 0.286 | Focal adhesion kinase 2 inhibitor | |||
| 0.279 | 0.014 | 0.279 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.286 | 0.028 | 0.286 | Src kinase inhibitor | |||
| 0.272 | 0.022 | 0.272 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.285 | 0.035 | 0.285 | CDC-like kinase 2 inhibitor | |||
| 0.246 | 0.016 | 0.246 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.25 | 0.025 | 0.25 | c-Src kinase inhibitor | |||
| 0.248 | 0.025 | 0.248 | Lck kinase inhibitor | |||
| 0.249 | 0.027 | 0.249 | Cyclin-dependent kinase inhibitor | |||
| 0.239 | 0.027 | 0.239 | Tubulin antagonist | |||
| 0.264 | 0.053 | 0.264 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.219 | 0.009 | 0.219 | MAP3K9 inhibitor | 0.159 0.047 CID_18445712 0.16 0.046 CID_18445703 | ||
| 0.23 | 0.021 | 0.23 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.224 | 0.015 | 0.224 | MAP kinase 3 inhibitor | |||
| 0.224 | 0.016 | 0.224 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.258 | 0.052 | 0.258 | Clk dual-specificity kinase inhibitor | |||
| 0.223 | 0.023 | 0.223 | ATPase inhibitor | 0.19 0.047 CID_18445712 | ||
| 0.261 | 0.067 | 0.261 | Dyrk kinase inhibitor | |||
| 0.274 | 0.08 | 0.274 | Hypoxia-inducible factor 1 alpha inhibitor | 0.263 0.089 CID_18445703 | ||
| 0.24 | 0.051 | 0.24 | TRKC antagonist | |||
| 0.222 | 0.036 | 0.222 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.218 | 0.034 | 0.218 | Protein kinase (CK1) inhibitor | |||
| 0.235 | 0.051 | 0.235 | CDC-like kinase 4 inhibitor | |||
| 0.241 | 0.058 | 0.241 | MAP kinase kinase 2 inhibitor | |||
| 0.217 | 0.034 | 0.217 | Tyrosine-protein kinase receptor antagonist | |||
| 0.224 | 0.044 | 0.224 | Growth factor agonist | |||
| 0.188 | 0.009 | 0.188 | Protein kinase B gamma inhibitor | |||
| 0.233 | 0.054 | 0.233 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.335 | 0.158 | 0.387 | Caspase 9 stimulant | 0.387 0.119 CID_18445703 | CID_18445703 | |
| 0.214 | 0.042 | 0.214 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.19 | 0.019 | 0.19 | Platelet activating factor alpha antagonist | |||
| 0.197 | 0.03 | 0.197 | Protein kinase (CK1) delta inhibitor | |||
| 0.181 | 0.014 | 0.181 | Insulin growth factor antagonist | |||
| 0.219 | 0.054 | 0.219 | LIM domain kinase 1 inhibitor | |||
| 0.185 | 0.023 | 0.185 | Interleukin 1b antagonist | |||
| 0.179 | 0.019 | 0.179 | EphA2 antagonist | |||
| 0.172 | 0.014 | 0.172 | Insulin like growth factor 1 antagonist | |||
| 0.185 | 0.034 | 0.185 | TRKA antagonist | |||
| 0.173 | 0.024 | 0.173 | CDK/cyclin complex inhibitor | |||
| 0.154 | 0.009 | 0.154 | TRPA1 antagonist | |||
| 0.189 | 0.044 | 0.189 | Death-associated protein kinase 2 inhibitor | |||
| 0.16 | 0.017 | 0.16 | MAP kinase 14 inhibitor | |||
| 0.173 | 0.031 | 0.173 | Ephrin antagonist | |||
| 0.182 | 0.041 | 0.182 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.173 | 0.033 | 0.173 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.149 | 0.01 | 0.149 | Cyclin E inhibitor | |||
| 0.16 | 0.021 | 0.16 | Epidermal growth factor antagonist | |||
| 0.159 | 0.021 | 0.159 | CDK3/cyclin E inhibitor | |||
| 0.215 | 0.077 | 0.215 | EphB2 antagonist | |||
| 0.18 | 0.047 | 0.18 | Activin receptor-like kinase 2 inhibitor | |||
| 0.157 | 0.026 | 0.157 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.2 | 0.071 | 0.2 | I kappa B kinase epsilon inhibitor | |||
| 0.144 | 0.022 | 0.144 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.142 | 0.021 | 0.142 | ALK inhibitor | |||
| 0.131 | 0.011 | 0.131 | Cyclin E1 inhibitor | |||
| 0.175 | 0.056 | 0.175 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.205 | 0.089 | 0.205 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.157 | 0.043 | 0.157 | TRKB antagonist | |||
| 0.148 | 0.037 | 0.148 | Polo-like kinase-4 inhibitor | |||
| 0.231 | 0.125 | 0.231 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.134 | 0.028 | 0.134 | Hepatocyte growth factor antagonist | |||
| 0.137 | 0.036 | 0.137 | Fibroblast growth factor 1 antagonist | |||
| 0.138 | 0.037 | 0.138 | Check point kinase 2 inhibitor | |||
| 0.118 | 0.018 | 0.118 | CDK2/cyclin E inhibitor | |||
| 0.159 | 0.059 | 0.159 | Ribosomal protein S6 kinase inhibitor | |||
| 0.127 | 0.028 | 0.127 | ErbB-4 antagonist | |||
| 0.154 | 0.054 | 0.154 | MAP kinase kinase 4 inhibitor | 0.127 0.124 CID_18445712 | ||
| 0.133 | 0.034 | 0.133 | CDK2/cyclin A inhibitor | |||
| 0.147 | 0.054 | 0.147 | Aurora-C kinase inhibitor | |||
| 0.135 | 0.043 | 0.135 | MAP kinase kinase kinase inhibitor | |||
| 0.13 | 0.038 | 0.13 | MAP kinase 8 inhibitor | |||
| 0.118 | 0.028 | 0.118 | ErbB-2 antagonist | |||
| 0.139 | 0.049 | 0.139 | Protein kinase (CK2) alpha inhibitor | |||
| 0.15 | 0.061 | 0.15 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.119 | 0.03 | 0.119 | Platelet growth factor antagonist | |||
| 0.139 | 0.05 | 0.139 | MAP kinase 12 inhibitor | |||
| 0.215 | 0.127 | 0.215 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.182 | 0.096 | 0.182 | Histone acetyltransferase inhibitor | |||
| 0.108 | 0.023 | 0.108 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.131 | 0.047 | 0.131 | MAP kinase 13 inhibitor | |||
| 0.14 | 0.057 | 0.14 | MAP kinase kinase inhibitor | |||
| 0.276 | 0.194 | 0.276 | 5 Hydroxytryptamine release inhibitor | |||
| 0.112 | 0.031 | 0.112 | AXL receptor tyrosine kinase inhibitor | |||
| 0.133 | 0.054 | 0.133 | Beta amyloid protein antagonist | |||
| 0.092 | 0.012 | 0.092 | Transforming growth factor beta 1 antagonist | |||
| 0.09 | 0.011 | 0.09 | Cyclin D1 inhibitor | |||
| 0.113 | 0.035 | 0.113 | Stem cell growth factor agonist | |||
| 0.113 | 0.037 | 0.113 | Protein kinase A inhibitor | |||
| 0.118 | 0.043 | 0.118 | Insulin receptor antagonist | |||
| 0.139 | 0.066 | 0.139 | Interleukin 1 antagonist | |||
| 0.102 | 0.033 | 0.102 | MAP kinase 10 inhibitor | |||
| 0.115 | 0.048 | 0.115 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.148 | 0.086 | 0.148 | Polo-like kinase-3 inhibitor | |||
| 0.096 | 0.038 | 0.096 | MAP kinase 11 inhibitor | |||
| 0.098 | 0.04 | 0.098 | MAP-kinase-activated kinase inhibitor | |||
| 0.086 | 0.029 | 0.086 | Transforming growth factor antagonist | |||
| 0.115 | 0.062 | 0.115 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.077 | 0.025 | 0.077 | EphB4 antagonist | |||
| 0.285 | 0.234 | 0.285 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.082 | 0.032 | 0.082 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.169 | 0.121 | 0.169 | Aryl hydrocarbon receptor agonist | |||
| 0.087 | 0.04 | 0.087 | Rho-associated kinase II inhibitor | |||
| 0.202 | 0.155 | 0.202 | Nootropic | |||
| 0.099 | 0.052 | 0.099 | Protein kinase C zeta inhibitor | |||
| 0.105 | 0.059 | 0.105 | Protein kinase (CK2) inhibitor | |||
| 0.084 | 0.04 | 0.084 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.1 | 0.056 | 0.1 | MAP kinase kinase 1 inhibitor | |||
| 0.065 | 0.022 | 0.065 | Dihydroorotate oxidase inhibitor | |||
| 0.08 | 0.039 | 0.08 | CDK2/cyclin E2 inhibitor | |||
| 0.09 | 0.049 | 0.09 | TIE antagonist | |||
| 0.089 | 0.048 | 0.089 | TIE-2 antagonist | |||
| 0.073 | 0.032 | 0.073 | Raf kinase B inhibitor | |||
| 0.077 | 0.036 | 0.077 | Fibroblast growth factor 2 antagonist | |||
| 0.101 | 0.062 | 0.101 | MAP kinase 9 inhibitor | |||
| 0.086 | 0.047 | 0.086 | Transforming growth factor beta 3 antagonist | |||
| 0.166 | 0.127 | 0.166 | Antiamyloidogenic | 0.156 0.139 CID_18445712 | ||
| 0.088 | 0.051 | 0.088 | ErbB-3 antagonist | |||
| 0.097 | 0.061 | 0.097 | Pim-1 kinase inhibitor | |||
| 0.081 | 0.044 | 0.081 | Raf kinase inhibitor | |||
| 0.092 | 0.058 | 0.092 | Polo-like kinase-1 inhibitor | |||
| 0.074 | 0.041 | 0.074 | Phosphodiesterase 4B inhibitor | |||
| 0.081 | 0.048 | 0.081 | Focal adhesion kinase 1 inhibitor | |||
| 0.05 | 0.017 | 0.05 | Alpha 1d adrenoreceptor agonist | |||
| 0.038 | 0.01 | 0.038 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.032 | 0.005 | 0.032 | Alpha 2a adrenoreceptor agonist | |||
| 0.121 | 0.094 | 0.121 | CDC-like kinase 1 inhibitor | |||
| 0.088 | 0.061 | 0.088 | Pim-3 kinase inhibitor | |||
| 0.07 | 0.047 | 0.07 | Protein kinase C beta inhibitor | |||
| 0.053 | 0.03 | 0.053 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.048 | 0.026 | 0.048 | Secretase gamma inhibitor | |||
| 0.078 | 0.058 | 0.078 | Phosphodiesterase 3A inhibitor | |||
| 0.069 | 0.051 | 0.069 | Syk tyrosine kinase inhibitor | |||
| 0.064 | 0.05 | 0.064 | Vanilloid 1 antagonist | |||
| 0.106 | 0.093 | 0.106 | M17 leucyl aminopeptidase inhibitor | |||
| 0.096 | 0.085 | 0.096 | Protein kinase C gamma inhibitor | |||
| 0.076 | 0.066 | 0.076 | Phosphodiesterase IV inhibitor | |||
| 0.117 | 0.106 | 0.117 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.062 | 0.054 | 0.062 | Cyclin B3 inhibitor | |||
| 0.012 | 0.005 | 0.012 | CD80 antagonist | |||
| 0.052 | 0.047 | 0.052 | CDK4/cyclin D1 inhibitor | |||
| 0.04 | 0.034 | 0.04 | Glutamate (mGluR group III) agonist | |||
| 0.054 | 0.048 | 0.054 | CDK4/cyclin D inhibitor | |||
| 0.104 | 0.099 | 0.104 | Cathepsin H inhibitor | |||
| 0.029 | 0.025 | 0.029 | Potassium channel small-conductance Ca-activated activator | |||
| 0.064 | 0.06 | 0.064 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.055 | 0.052 | 0.055 | CDK1/cyclin B inhibitor | |||
| 0.026 | 0.023 | 0.026 | Cyclin E2 inhibitor | |||
| 0.053 | 0.052 | 0.053 | Alpha 2 adrenoreceptor agonist | |||
| 0.112 | 0.189 | 0.146 | Lipocortins synthesis antagonist | 0.146 0.111 CID_18445712 0.145 0.113 CID_18445703 | CID_18445712 | |
| 0.111 | 0.244 | 0.176 | Cyclic AMP phosphodiesterase inhibitor | 0.158 0.139 CID_18445712 0.176 0.115 CID_18445703 | CID_18445703 | |
| 0.055 | 0.194 | 0.139 | Beta glucuronidase inhibitor | 0.139 0.03 CID_18445712 | CID_18445712 | |
| 0.078 | 0.243 | 0.155 | NOS3 expression enhancer | 0.155 0.067 CID_18445703 | CID_18445703 | |
| 0.051 | 0.219 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.049 CID_18445703 | CID_18445703 | |
| 0.098 | 0.302 | 0.125 | CC chemokine 6 receptor antagonist | 0.121 0.114 CID_18445712 0.125 0.093 CID_18445703 | CID_18445703 | |
| 0.12 | 0.37 | 0.207 | Caspase 3 stimulant | 0.207 0.16 CID_18445703 | CID_18445703 | |
| 0.012 | 0.272 | 0.06 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 CID_18445703 | CID_18445703 | |
| 0.007 | 0.268 | 0.044 | Phosphorylase inhibitor | 0.044 0.034 CID_18445712 | CID_18445712 | |
| 0.089 | 0.372 | 0.151 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.151 0.147 CID_18445703 | CID_18445703 | |
| 0.022 | 0.316 | 0.173 | Topoisomerase I inhibitor | 0.097 0.073 CID_18445712 0.173 0.033 CID_18445703 | CID_18445703 | |
| 0.005 | 0.301 | 0.013 | Adenosine A2b receptor agonist | 0.013 0.012 CID_18445703 | CID_18445703 | |
| 0.139 | 0.438 | 0.347 | Antiinflammatory | 0.347 0.175 CID_18445703 | CID_18445703 | |
| 0.004 | 0.32 | 0.03 | Adenosine A1 receptor agonist | 0.03 0.011 CID_18445703 | CID_18445703 | |
| 0.006 | 0.333 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.014 CID_18445703 | CID_18445703 | |
| 0.106 | 0.456 | 0.34 | Apoptosis agonist | 0.34 0.145 CID_18445703 | CID_18445703 | |
| 0.059 | 0.437 | 0.274 | DNA synthesis inhibitor | 0.257 0.062 CID_18445712 0.274 0.054 CID_18445703 | CID_18445703 | |
| 0.035 | 0.473 | 0.209 | DNA methyltransferase I inhibitor | 0.209 0.065 CID_18445703 | CID_18445703 | |
| 0.037 | 0.478 | 0.128 | Nitric oxide antagonist | 0.128 0.122 CID_18445703 | CID_18445703 | |
| 0.035 | 0.501 | 0.224 | DNA methylase inhibitor | 0.224 0.064 CID_18445703 | CID_18445703 | |
| 0.025 | 0.528 | 0.177 | Free radical scavenger | 0.177 0.117 CID_18445712 | CID_18445712 | |
| 0.017 | 0.526 | 0.146 | Lipid peroxidase inhibitor | 0.146 0.071 CID_18445712 | CID_18445712 | |
| 0.025 | 0.579 | 0.212 | Antioxidant | 0.212 0.106 CID_18445712 | CID_18445712 | |
| 0.026 | 0.581 | 0.119 | Insulin secretagoues | 0.119 0.112 CID_18445703 | CID_18445703 | |
| 0.02 | 0.582 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.041 CID_18445703 | CID_18445703 | |
| 0.028 | 0.596 | 0.151 | Platelet adhesion inhibitor | 0.141 0.117 CID_18445712 0.151 0.104 CID_18445703 | CID_18445703 | |
| 0.034 | 0.622 | 0.162 | Hepatoprotectant | 0.16 0.099 CID_18445712 0.162 0.097 CID_18445703 | CID_18445703 | |
| 0.021 | 0.672 | 0.147 | DNA polymerase I inhibitor | 0.147 0.051 CID_18445703 | CID_18445703 | |
| 0.004 | 0.669 | 0.016 | Adenosine A3 receptor agonist | 0.016 0.014 CID_18445703 | CID_18445703 | |
| 0.034 | 0.705 | 0.304 | Cyclophilin D inhibitor | 0.26 0.202 CID_18445712 0.304 0.16 CID_18445703 | CID_18445703 | |
| 0.004 | 0.713 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CID_18445703 | CID_18445703 | |
| 0.027 | 0.739 | 0.255 | Immunomodulator | 0.194 0.172 CID_18445712 0.255 0.111 CID_18445703 | CID_18445703 | |
| 0.018 | 0.737 | 0.266 | Antibacterial | 0.239 0.187 CID_18445712 0.266 0.162 CID_18445703 | CID_18445703 | |
| 0.054 | 0.785 | 0.205 | Interleukin 2 agonist | 0.205 0.18 CID_18445712 0.205 0.18 CID_18445703 | CID_18445703 | |
| 0.008 | 0.743 | 0.087 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.064 CID_18445703 | CID_18445703 | |
| 0.009 | 0.746 | 0.173 | Immunostimulant | 0.173 0.137 CID_18445703 | CID_18445703 | |
| 0.024 | 0.763 | 0.205 | Hypoglycemic | 0.205 0.107 CID_18445703 | CID_18445703 | |
| 0.016 | 0.813 | 0.211 | Immunosuppressant | 0.211 0.186 CID_18445703 | CID_18445703 | |
| 0.01 | 0.824 | 0.23 | Angiogenesis stimulant | 0.228 0.08 CID_18445712 0.23 0.079 CID_18445703 | CID_18445703 | |
| 0.04 | 0.969 | 0.276 | Peptidyltransferase inhibitor | 0.204 0.094 CID_18445712 0.276 0.035 CID_18445703 | CID_18445703 | |
| 0.003 | 0.94 | 0.074 | Selectin antagonist | 0.074 0.04 CID_18445712 | CID_18445712 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |